Glipizide Tablet
Product Images NDC 55154-7987

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 55154-7987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (Bf1f5a5d 79b0 4fc5 96f2 Bd5119b56e2a 00)

Bag Label (Bf1f5a5d 79b0 4fc5 96f2 Bd5119b56e2a 00)
Glipizide Tablets USP 5 mg oral tablets label from Cardinal Health 107, LLC. The label indicates a 10-tablet unit dose package and includes manufacturer and distributor information from Apotex Inc., Major Pharmaceuticals, and Cardinal Health. It provides usage warnings, storage instructions, and dispensing requirements.*
FDA Label Image

Glipizide-structure (Glipizide Structure)

Glipizide-structure (Glipizide Structure)
Chemical structure of the active ingredient Glipizide. The illustration depicts the molecular composition including ring structures and functional groups characteristic of Glipizide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.